Variant report
Variant | esv6146 |
---|---|
Chromosome Location | chr11:71861440-71862195 |
allele | n/a |
Outlinks | Ensembl   UCSC |
- TF binding region (count:0)
- CpG islands (count:0)
- Chromatin interactive region (count:1)
- LncRNA region (count:0)
- Mature miRNA region (count: 0)
- miRNA target sites (count:0)
No data |
No data |
(count:1 , 50 per page) page:
1
No. | Distal block | Cell Line | Cell type | Cell Stage |
---|---|---|---|---|
1 | chr11:71849346..71852118-chr11:71862000..71864280,2 | K562 | blood: |
No data |
No data |
No data |
Variant related genes | Relation type |
---|---|
ENSG00000110203 | chromatin interactions |

No. | Variant name | Chromosome position | Chromatin state | Related regulatory elements | Target genes | Extended variants | Associated traits |
---|---|---|---|---|---|---|---|
1 | rs59684857 | chr11:71861451-71861452 | Weak transcription | n/a | n/a | LD-proxies of rSNPOverlapped rCNV | mRNA abundance |
2 | rs556738613 | chr11:71861452-71861453 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
3 | rs34914877 | chr11:71861454-71861455 | Weak transcription | n/a | n/a | LD-proxies of rSNPOverlapped rCNV | n/a |
4 | rs541921855 | chr11:71861484-71861485 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
5 | rs189329644 | chr11:71861485-71861486 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
6 | rs572121697 | chr11:71861569-71861570 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
7 | rs369370415 | chr11:71861610-71861611 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
8 | rs373176715 | chr11:71861611-71861612 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
9 | rs376299448 | chr11:71861612-71861613 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
10 | rs369470391 | chr11:71861613-71861614 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
11 | rs373583999 | chr11:71861614-71861615 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
12 | rs11235452 | chr11:71861751-71861752 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
13 | rs11235453 | chr11:71861768-71861769 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
14 | rs11235454 | chr11:71861771-71861772 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
15 | rs181796813 | chr11:71861902-71861903 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
16 | rs546095753 | chr11:71861903-71861904 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
17 | rs185147534 | chr11:71861905-71861906 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
18 | rs564210111 | chr11:71861908-71861909 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
19 | rs377486909 | chr11:71861909-71861910 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
20 | rs113845195 | chr11:71861910-71861911 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
21 | rs370242046 | chr11:71861911-71861912 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
22 | rs377131350 | chr11:71861912-71861913 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
23 | rs547147524 | chr11:71862064-71862065 | Weak transcription Active TSS Enhancers Flanking Active TSS | Chromatin interactive region | 1 gene(s) | Overlapped CNVs | n/a |
24 | rs560752717 | chr11:71862100-71862101 | Weak transcription Active TSS Enhancers Flanking Active TSS | Chromatin interactive region | 1 gene(s) | Overlapped CNVs | n/a |
25 | rs111513534 | chr11:71862118-71862119 | Weak transcription Active TSS Enhancers Flanking Active TSS | Chromatin interactive region | 1 gene(s) | Overlapped CNVs | n/a |
26 | rs188298783 | chr11:71862122-71862123 | Weak transcription Active TSS Enhancers Flanking Active TSS | Chromatin interactive region | 1 gene(s) | Overlapped CNVs | n/a |
27 | rs571155712 | chr11:71862128-71862129 | Weak transcription Active TSS Enhancers Flanking Active TSS | Chromatin interactive region | 1 gene(s) | Overlapped CNVs | n/a |
Disease | PMID | Source |
---|---|---|
Medulloblastoma | 21979893 | CNVD |
Gastric cancer | 17908304 | CNVD |
Multiple myeloma | 20724749 | CNVD |
Wilms tumour | 21544195 | CNVD |
Autism | 22495311 | CNVD |
Chronic lymphocytic leukemia | 21546498 | CNVD |
Non-small cell lung cancer | 21385341 | CNVD |
Intellectual disability | 22102821 | CNVD |
Glioblastoma multiforme | 21138945 | CNVD |
Acute myeloid leukemia | 20729466 | CNVD |
Acute lymphoblastic leukemia | 20067559 | CNVD |
Cancer | 21637783 | CNVD |
Acute myeloid leukemia | 16864856 | CNVD |
Chronic lymphocytic leukemia | 21795749 | CNVD |
Esophageal squamous carcinoma | 21637470 | CNVD |
Neuroblastoma | 21484798 | CNVD |
Ewing''s sarcoma | 21437220 | CNVD |
Oral cancer | 21386901 | CNVD |
Endometrial cancer | 22040021 | CNVD |
Breast cancer | 20837533 | CNVD |
Breast cancer | 21264507 | CNVD |
Cervical cancer | 21063398 | CNVD |
Glioblastoma multiforme | 19960244 | CNVD |
Liposarcoma | 21253554 | CNVD |
Neuroblastoma | 18923524 | CNVD |
Neuroblastoma | 18664255 | CNVD |
Monoclonal gammopathy of undetermined significance | 17077331 | CNVD |
Multiple myeloma | 17077331 | CNVD |
Neuroblastoma | 17533364 | CNVD |
Acute lymphoblastic leukemia | 20435627 | CNVD |
Lung cancer | 18438408 | CNVD |
Basal cell lymphoma | 16317097 | CNVD |
Diffuse large b-cell lymphoma | 16317097 | CNVD |
Prostate cancer | 18632612 | CNVD |
Smith-Lemli-Opitz syndrome | 21572526 | CNVD |
Glioblastoma multiforme | 21080181 | CNVD |
Multiple myeloma | 16461302 | CNVD |
Cancer | 16751803 | CNVD |
Seminomas | 18059402 | CNVD |
Acute lymphoblastic leukemia | 21339820 | CNVD |
Chordoma | 21602918 | CNVD |
Metanephric adenoma | 20802469 | CNVD |
Melanoma | 18172304 | CNVD |
Breast cancer | 21806811 | CNVD |
Breast cancer | 22002566 | CNVD |
Ductal carcinoma | 18381933 | CNVD |
Retinoblastoma | 22278416 | CNVD |
Breast cancer | 20953835 | CNVD |
oto-dental syndrome | 17656375 | CNVD |
Asthma | 21956041 | CNVD |
Breast cancer | 17603634 | CNVD |
Ovarian neoplasms | 16753589 | CNVD |
Non-small cell lung cancer | 20864512 | CNVD |
Hepatocellular carcinoma | 16750200 | CNVD |
Cervical cancer | 21062161 | CNVD |
Breast cancer | 21509527 | CNVD |
Breast cancer | 17001317 | CNVD |
Oral squamous cell carcinoma | 16619035 | CNVD |
Intracranial aneurysm | 16715129 | CNVD |
Colorectal cancer | 16272173 | CNVD |
Primary mediastinal b-cell lymphoma | 17728785 | CNVD |
Esophageal adenocarcinoma | 18820669 | CNVD |
Colorectal cancer | 16882699 | CNVD |
Berardinelli-seip congenital generalized lipodystrophy | 17668395 | CNVD |
Spinal muscular atrophy | 17668395 | CNVD |
Neonatal seizures | 17668395 | CNVD |
Neonatal seizures | 17668391 | CNVD |
Neuroticism | 17667963 | CNVD |
Cancer | 17916600 | CNVD |
Squamous cell cancer | 19047905 | CNVD |
Multiple endocrine neoplasia type 1 | 19566914 | CNVD |
XY sex reversal | 17503084 | CNVD |
Berardinelli-seip congenital generalized lipodystrophy | 17668391 | CNVD |
Maculopathy | 17646752 | CNVD |
Breast cancer | 17899364 | CNVD |
Breast cancer | 17157792 | CNVD |
Esophageal squamous carcinoma | 18350619 | CNVD |
Hodgkin''s lymphoma | 17606441 | CNVD |
T-cell prolymphocytic leukemia | 19278963 | CNVD |
Cancer | 20164919 | CNVD |
Hodgkin''s lymphoma | 18641027 | CNVD |
Breast cancer | 21364760 | CNVD |
lymphocytic leukemia | 21291569 | CNVD |
Myelofibrosis | 22110671 | CNVD |
Ovarian clear cell carcinoma | 19293255 | CNVD |
Cancer | 22183965 | CNVD |
Melanoma | 22183965 | CNVD |
Esophageal squamous carcinoma | 18405350 | CNVD |
Breast cancer | 16620391 | CNVD |
Multiple myeloma | 17550852 | CNVD |
Neuroblastoma | 18923191 | CNVD |
low-grade B-cell lymphoma tumor | 18367492 | CNVD |
Chronic lymphocytic leukemia | 22228453 | CNVD |
Multiple myeloma | 16616336 | CNVD |
Urothelial cell carcinoma | 18451213 | CNVD |
Leukoplakia | 24403051 | CNVD |
Prostate cancer | 17217626 | CNVD |
Cancer | 22429812 | CNVD |
small cell lung cancer | 20016488 | CNVD |
Pancreatic ductal adenocarcinoma | 19077451 | CNVD |
Breast cancer | 17142309 | CNVD |
No. | Chromosome Location | Chromatin state | Cell line | Tissue |
---|---|---|---|---|
1 | chr11:71857000-71863600 | Weak transcription | Placenta | Placenta |
2 | chr11:71857800-71862200 | Weak transcription | Foreskin Keratinocyte Primary Cells skin02 | Skin |
3 | chr11:71861000-71862000 | Weak transcription | Foreskin Keratinocyte Primary Cells skin03 | Skin |
4 | chr11:71861000-71862000 | Weak transcription | NHEK | skin |
5 | chr11:71862000-71862600 | Enhancers | K562 | blood |
6 | chr11:71862000-71862600 | Flanking Active TSS | NHEK | skin |
7 | chr11:71862000-71863600 | Active TSS | Foreskin Keratinocyte Primary Cells skin03 | Skin |